Literature DB >> 12115512

Improved survival in both histologic types of oesophageal cancer in Sweden.

Martin Sundelöf1, Weimin Ye, Paul W Dickman, Jesper Lagergren.   

Abstract

The prognosis among patients diagnosed with oesophageal cancer is poor with an overall 5-year survival close to 5% in most countries. Improved diagnostic and surgical strategies might influence the survival, however. We investigated the observed and relative survival among all patients in Sweden diagnosed with oesophageal adenocarcinoma (n = 1,441) or squamous cell carcinoma (n = 6395) from 1961-1996 with follow-up to December 1997. Observed survival rates were calculated by the life-table method. Relative survival rates were computed as the ratio of the observed to the expected survival. The expected survival was inferred from the survival among the entire Swedish population in the same age, sex and calendar year strata. The 5-year observed survival rate for adenocarcinoma increased from a stable figure close to 4% during the entire period 1961-1989 to 10.5% during 1990-1996. Similarly, the 5-year relative survival rate was stable around 5% during 1961-1989, but during 1990-1996 the survival was increased to 13.7%. For squamous cell carcinoma, the survival improved slightly by each decade, starting with 3.8% 5-year observed survival in 1961-1969 to 7.0% during 1990-1996. Similarly, the 5-year relative survival improved from 5.0% to 8.9% during the study period. In conclusion, the survival rates for both oesophageal adenocarcinoma and squamous cell carcinoma have increased significantly during the 1990s compared to those in the previous 3 decades (p < 0.001). Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12115512     DOI: 10.1002/ijc.10420

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

Authors:  L Murray; A Sedo; M Scott; D McManus; J M Sloan; L J Hardie; D Forman; C P Wild
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

3.  A comprehensive review of esophageal stents.

Authors:  Pierre Hindy; Jinwha Hong; Yvette Lam-Tsai; Frank Gress
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-08

4.  Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection.

Authors:  Pernilla Viklund; Mats Lindblad; Jesper Lagergren
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Imaging of esophageal stent with convex probe endobronchial ultrasound.

Authors:  Abdul Hamid Alraiyes; Kassem Harris; Samjot Singh Dhillon
Journal:  Endosc Ultrasound       Date:  2016 Mar-Apr       Impact factor: 5.628

6.  Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis.

Authors:  Jayant P Talreja; Mohamad A Eloubeidi; Bryan G Sauer; Basil S Al-Awabdy; Tercio Lopes; Michel Kahaleh; Vanessa M Shami
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

7.  A novel fully covered self-expandable segmental metallic stents for the treatment of refractory esophageal stenosis.

Authors:  Yonghua Bi; Jianzhuang Ren; Jindong Li; Zepeng Yu; Xinwei Han; Gang Wu
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

8.  Psychosocial working conditions and the risk of esophageal and gastric cardia cancers.

Authors:  Catarina Jansson; Anna L V Johansson; Kerstin Jeding; Paul W Dickman; Olof Nyrén; Jesper Lagergren
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia.

Authors:  Martin Sundelöf; Jesper Lagergren; Weimin Ye
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

10.  Diverging trends in recent population-based survival rates in oesophageal and gastric cancer.

Authors:  Jesper Lagergren; Fredrik Mattsson; Fredrik Mattson
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.